Finance

Lists
301263:SHE
Guangdong Taienkang Pharmaceut Co Ltd
CN¥17.75
-1.33%
(-0.24) 1D
Nov 17, 3:04:49 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301263...
Open
CN¥17.97
High
CN¥18.17
Low
CN¥17.72
Mkt. cap
9.19B
Avg. vol.
3.64M
Volume
3.12M
Dividend
0.23%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 1, 2026
P/E ratio
317.87
52-wk high
CN¥29.78
52-wk low
CN¥16.88
EPS
CN¥0.06
Shares outstanding
510.60M
No. of employees
1K
Open
CN¥17.97
High
CN¥18.17
Low
CN¥17.72
Mkt. cap
9.19B
Avg. vol.
3.64M
Volume
3.12M
Dividend
0.23%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 1, 2026
P/E ratio
317.87
52-wk high
CN¥29.78
52-wk low
CN¥16.88
EPS
CN¥0.06
Shares outstanding
510.60M
No. of employees
1K
News stories
From web sources and news partners
About Guangdong Taienkang Pharmaceut Co Ltd
CEO-
Employees1.15K
FoundedJan 22, 1999
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
149.07M
189.52M
130.76M
212.41M
Cost of goods sold
84.18M
70.35M
74.87M
76.76M
Cost of revenue
84.18M
70.35M
74.87M
76.76M
Research and development expenses
23.44M
13.59M
16.93M
14.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.31M
70.73M
84.21M
91.61M
Operating expense
83.83M
85.13M
106.92M
106.98M
Total operating expenses
168.01M
155.47M
181.78M
183.74M
Operating income
-18.94M
34.04M
-51.02M
28.67M
Other non operating income
-512.13K
-612.31K
717.14K
607.94K
EBT including unusual items
-27.84M
30.45M
-47.35M
26.37M
EBT excluding unusual items
-22.67M
31.60M
-49.54M
26.74M
Income tax expense
-18.62M
5.53M
-18.45M
2.45M
Effective tax rate
66.87%
18.18%
38.98%
9.31%
Other operating expenses
685.26K
816.63K
1.71M
562.42K
Net income
-2.77M
28.58M
-24.86M
27.76M
Net profit margin
-1.86%
15.08%
-19.01%
13.07%
Earnings per share
-
-
-
-
Interest and investment income
3.23M
1.49M
4.10M
1.74M
Interest expense
-5.88M
-3.33M
-3.38M
-4.22M
Net interest expenses
-2.65M
-1.83M
720.71K
-2.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.00M
49.98M
-34.32M
44.61M
Gain or loss from assets sale
-193.19K
-
78.42K
-78.42K
Upcoming events
AI content may include mistakes. Learn more
Google apps